Literature DB >> 20645963

Repeatability of sleep apnea detection in 48-hour holter ECG monitoring.

Barbara Uznańska1, Ewa Trzos, Tomasz Rechciński, Jarosław D Kasprzak, Małgorzata Kurpesa.   

Abstract

BACKGROUND: There is a significant relationship between obstructive sleep apnea (OSA) and cardiovascular diseases. Reliability of new methods evaluating apnea in Holter ECG monitoring is still the matter of investigators' studies.
METHODS: In 48-hour Holter ECG monitoring recordings of 63 patients, we assessed repeatability, comparing the results from both sleep periods.
RESULTS: We found good repeatability in evaluation of apnea-hypopnea index value. There was moderate agreement in three categories, that is, normal or bordeline or apneic assignment. Assignment to "healthy" (normal and borderline) or apneic subgroup during consecutive sleep periods showed high repeatability.
CONCLUSIONS: Holter ECG monitoring is a repetitive method of preliminary diagnosis in patients evaluated for sleep apnea syndrome.

Entities:  

Mesh:

Year:  2010        PMID: 20645963      PMCID: PMC6931987          DOI: 10.1111/j.1542-474X.2010.00367.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  13 in total

1.  Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health).

Authors:  Virend K Somers; David P White; Raouf Amin; William T Abraham; Fernando Costa; Antonio Culebras; Stephen Daniels; John S Floras; Carl E Hunt; Lyle J Olson; Thomas G Pickering; Richard Russell; Mary Woo; Terry Young
Journal:  Circulation       Date:  2008-08-25       Impact factor: 29.690

2.  Short-term variability of respiration and sleep during unattended nonlaboratory polysomnography--the Sleep Heart Health Study. [corrected].

Authors:  Stuart F Quan; Michael E Griswold; Conrad Iber; F Javier Nieto; David M Rapoport; Susan Redline; Mark Sanders; Terry Young
Journal:  Sleep       Date:  2002-12       Impact factor: 5.849

3.  Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome.

Authors:  A T Whittle; S P Finch; I L Mortimore; T W MacKay; N J Douglas
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

4.  Night-to-night variability in sleep apnea and sleep-related periodic leg movements in the elderly.

Authors:  S S Mosko; M J Dickel; J Ashurst
Journal:  Sleep       Date:  1988-08       Impact factor: 5.849

5.  Influence of setting on unattended respiratory monitoring in the sleep apnoea/hypopnoea syndrome.

Authors:  P Lloberes; G Sampol; G Levy; D Aristizabal; T Sagales; M De la Calzada; A Roca; I Cañas; F Morell
Journal:  Eur Respir J       Date:  2001-09       Impact factor: 16.671

6.  Night-to-night variation of the oxygen desaturation index in sleep apnoea syndrome.

Authors:  I Fietze; K Dingli; K Diefenbach; N J Douglas; M Glos; M Tallafuss; W Terhalle; C Witt
Journal:  Eur Respir J       Date:  2004-12       Impact factor: 16.671

7.  Use of the sleep laboratory in suspected sleep apnea syndrome: is one night enough?

Authors:  W B Mendelson
Journal:  Cleve Clin J Med       Date:  1994 Jul-Aug       Impact factor: 2.321

8.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A J Struijker Boudier; Alberto Zanchetti; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Gerasimos Filippatos; Christian Funck-Brentano; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; Jose Luis Zamorano; Sverre E Kjeldsen; Serap Erdine; Krzysztof Narkiewicz; Wolfgang Kiowski; Enrico Agabiti-Rosei; Ettore Ambrosioni; Renata Cifkova; Anna Dominiczak; Robert Fagard; Anthony M Heagerty; Stephane Laurent; Lars H Lindholm; Giuseppe Mancia; Athanasios Manolis; Peter M Nilsson; Josep Redon; Roland E Schmieder; Harry A J Struijker-Boudier; Margus Viigimaa; Gerasimos Filippatos; Stamatis Adamopoulos; Enrico Agabiti-Rosei; Ettore Ambrosioni; Vicente Bertomeu; Denis Clement; Serap Erdine; Csaba Farsang; Dan Gaita; Wolfgang Kiowski; Gregory Lip; Jean-Michel Mallion; Athanasios J Manolis; Peter M Nilsson; Eoin O'Brien; Piotr Ponikowski; Josep Redon; Frank Ruschitzka; Juan Tamargo; Pieter van Zwieten; Margus Viigimaa; Bernard Waeber; Bryan Williams; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2007-06-11       Impact factor: 29.983

9.  Low night-to-night variability of sleep disordered breathing in patients with stable congestive heart failure.

Authors:  Olaf Oldenburg; Barbara Lamp; Klaus Freivogel; Thomas Bitter; Christoph Langer; Dieter Horstkotte
Journal:  Clin Res Cardiol       Date:  2008-07-21       Impact factor: 5.460

10.  Usefulness of ambulatory ECG in the diagnosis of sleep-related breathing disorders.

Authors:  Stefan Ozegowski; Ewa Wilczyńska; Tomasz Piorunek; Katarzyna Szymanowska; Lech Paluszkiewicz
Journal:  Kardiol Pol       Date:  2007-11       Impact factor: 3.108

View more
  1 in total

1.  Usefulness of extended holter ECG monitoring for serious arrhythmia detection in patients with heart failure and sleep apnea.

Authors:  Barbara Uznańska-Loch; Ewa Trzos; Karina Wierzbowska-Drabik; Janusz Smigielski; Tomasz Rechciński; Urszula Cieślik-Guerra; Jarosław D Kasprzak; Małgorzata Kurpesa
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.